Tonix Pharmaceuticals Holding Corp.
TNXP
NSC
Sector: Healthcare
Industry: Biotechnology
0.56
USD
0.03
(4.93%)
Optionable: No Market Cap: 24 M 90-day average vol: 7,176,667
Previous close: 0.5356 Open: 0.52 Bid: 0.567 Ask: 0.567
52 week range
0.52 20.00
Last updated: Thursday 29th September 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 0.00 |
Price per Book TTM ($) | 0.14 |
PE Ratio (TTM) | -0.10 |
Book Value per Share ($) | 0.43 |
5 Year PE Range | NA , NA |
Returns
7 Day Return | -12.20% | |
1 Month Return | -44.90% | |
3 Month Return | -64.43% | |
1 Year Return | -97.02% | |
3 Year Return | -99.56% | |
5 Year Return | -100.00% | |
YTD Return | -95.09% |
Risk
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 24.13 |
14 Day SMA ($) | 0.73 |
14 Day EMA ($) | 0.70 |
Money Flow Index | 48.11 |
Average True Range | 0.08 |
50 Day SMA ($) | 1.20 |
200 Day SMA ($) | 4.79 |
ADX | 35.93 |
MACD | -0.19 |
Growth
Free Cash Flow QoQ Growth | -30.53% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | -23.75% |
Revenue QoQ Growth | 0.00% |
EPS YoY Growth | 0.00% |
Profitability
News
Financials
TNXP Income Statement
Annual
| Dec-12 | Dec-13 | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of sales | -14000 | -17000 | -36000 | -161000 | -206000 | -70000 | -54000 | -26000 | -27000 | -50000 |
| Gross operating profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling Gen & administrative expense | 7 M | 11 M | 28 M | 48 M | 39 M | 21 M | 26 M | 29 M | 51 M | 92 M |
| Research & development expense | 3 M | 5 M | 19 M | 36 M | 29 M | 13 M | 18 M | 18 M | 36 M | 69 M |
| Operating income | -7 M | -11 M | -28 M | -48 M | -39 M | -21 M | -26 M | -29 M | -51 M | -92 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | -1 M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-tax Income (EBT) | -9 M | -11 M | -28 M | -48 M | -39 M | -21 M | -26 M | -29 M | -50 M | -92 M |
| Income taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from total operations | -9 M | -11 M | -28 M | -48 M | -39 M | -21 M | -26 M | -29 M | -50 M | -92 M |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | -9 M | -11 M | -28 M | -48 M | -39 M | -21 M | -26 M | -29 M | -50 M | -92 M |
| Preferred dividends | N/A | N/A | N/A | N/A | N/A | N/A | 3 M | 2 M | 1 M | N/A |
| Net income available for common | -9 M | -11 M | -28 M | -48 M | -39 M | -21 M | -29 M | -31 M | -52 M | -92 M |
| Depreciation | 14000 | 17000 | 36000 | 161000 | 206000 | 70000 | 54000 | 26000 | 27000 | 50000 |
| Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income before depreciation (EBITDA) | -8 M | -11 M | -28 M | -48 M | -39 M | -21 M | -26 M | -29 M | -50 M | -92 M |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | -5600 | -3370 | -2770 | -2860 | -1541 | -316.9 | -259.85 | -19.33 | -17.6 | -8.32 |
| Diluted EPS total | -5600 | -3370 | -2770 | -2860 | -1541 | -316.9 | -259.85 | -19.33 | -17.6 | -8.32 |
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONSGet started today